Related Experiment Videos
The relation between endothelin-1 levels and myocardial injury in chronic ischemic heart failure
Mustafa Yazici1, Sabri Demircan, Kenan Durna
1Department of Cardiology, Ondokuz Mayis University Medical School, 55139 Kurupelit, Samsun, Turkey. drmeyaz@hotmail.com
Insights
Elevated endothelin-1 (ET-1) levels correlate with myocardial injury and reduced ejection fraction in chronic ischemic heart failure patients. This suggests ET-1 contributes to disease progression and cardiac dysfunction.
Area of Science:
- Cardiology
- Biochemistry
- Heart Failure Research
Background:
- Endothelin-1 (ET-1) is implicated in the progression of ischemic heart failure.
- The relationship between ET-1 and myocardial injury markers needs further clarification.
Purpose of the Study:
- To investigate the association between endothelin-1 (ET-1) levels and myocardial injury in patients with chronic ischemic heart failure.
- To explore the correlation between ET-1, cardiac troponin-I (cTn-I), and ejection fraction.
Main Methods:
- Cross-sectional study including 121 chronic ischemic heart failure patients and 37 healthy controls.
- Measurement of plasma endothelin-1 (ET-1) and cardiac troponin-I (cTn-I) levels.
- Echocardiographic assessment of ejection fraction and New York Heart Association (NYHA) functional classification.
Main Results:
- ET-1 levels were significantly higher in heart failure patients than controls and increased with NYHA class severity.
- Elevated cTn-I levels correlated with increased ET-1 and decreased ejection fraction.
- A negative correlation was observed between ejection fraction and ET-1 levels (r = -0.312, P = 0.019).
Conclusions:
- Increased ET-1 levels are associated with myocardial injury, indicated by elevated cTn-I.
- ET-1 may contribute to the progression of chronic ischemic heart failure by exacerbating myocardial injury and reducing ejection fraction.
Abstract:
We evaluated whether there was any relation between myocardial injury and endothelin-1 (ET-1) levels, which has been suggested as a contributor to the progression of ischemic heart failure. One hundred and twenty-one patients with chronic ischemic heart failure and 37 healthy individuals were included in the study. Cardiac troponin-I (cTn-I) and ET-1 levels of all subjects were measured on admission. Echocardiographic evaluations were also performed. The positivity of cTn-I increased significantly as the severity changed from New York Heart Association (NHYA) Class I to IV (P < 0.01). This was also true for quantitative cTn-I levels (P < 0.05). The ET-1 levels of patients were higher than controls on admission (P < 0.001). The ET-1 levels increased significantly upon the progression from NHYA Class I to IV (P < 0.001). Moreover, patients with cTn-I positivity had higher ET-1 levels (P < 0.05) and a lower ejection fraction (P < 0.001). A negative correlation was found between ejection fraction and the ET-1 levels (r = -0.312, P = 0.019). In patients with cTn-I positivity, the cTn-I levels showed a positive correlation with the ET-1 levels (r = 0.328, P = 0.014) and a negative correlation with ejection fraction (r = -0.671, P < 0.001). In chronic ischemic heart failure, an increase in ET-1 may exert an influence on the progression of cardiac failure by leading to myocardial injury which may be demonstrated by higher cTn-I levels.
Related Concept Videos
Myocarditis I: Introduction
Heart Failure II: Pathophysiology
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...